Methods of treating bipolar disorders

STATINS FOR THE TREATMENT OF OCULAR HYPERTENSION AND GLAUCOMA

STATIN AND OMEGA-3 FATTY ACIDS FOR LIPID THERAPY

Amino acid composition for improving glucose tolerance

MEDICAMENT FOR USE IN CONNECTION WITH CARTILAGE IMPAIRMENT

Selective inhibitors of histone deacetylase

Ophthalmic pharmaceutical compositions based on amino acids and sodium hyaluronate

Potentiators of insulin secretion

Wound-healing pharmaceutical compositions in the form of a cream based on amino acids and sodium hyaluronate

Combination therapy comprising SGLT inhibitors and DPP4 inhibitors

Methods of controlling proliferation and differentiation of stem and progenitor cells

Gabapentin for the Treatment of Overactive Bladder, Stress Incontinence and BPH

Dosage regimen of an S1P receptor agonist

Nutritional supplements

Combination of Oral Medicaments Bonded by a Wrapping

Amino acid derivatives used as pharmaceutical substances

CONTROLLED RELEASE FORMULATIONS

Compound capable of binding S1P receptor and pharmaceutical use thereof

Compositions and methods for wound care

Inhibitors of Jun N-terminal kinase

Nutritive compositions and methods of using same

BEVERAGE COMPOSITIONS FOR THE PROMOTION OF JOINT HEALTH IN COMPANION ANIMALS

Nitric oxide amino acid ester compound, composition for increasing nitric oxide levels and method of use

COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL

COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

Methods for identifying GLP-1 secretagogues

COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL

Methods for Treating Disorders Associated with Hyperlipidemia in a Mammal

ANTI-FATIGUE AGENT COMPRISING AMINO ACID COMPOSITION

1-BUTANE ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING SAID DERIVATIVES AND THE USE THEREOF

Kallikrein 7 modulators

SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS) AND USES THEREOF

Oral composition

Fluorene compound and pharmaceutical use thereof

Susceptibility Gene for Myocardial Infarction, Stroke, and PAOD; Methods of Treatment

COMPOSITIONS AND TREATMENT OF HEART DEFICIENCY IN NON-HUMAN ANIMALS

OCULOSELECTIVE DRUGS AND PRODRUGS

Compositions for accelerating the production of collagen-containing proteins

COMBINATIONS USEFUL FOR THE TREATMENT OF NEURONAL DISORDERS

Systems and methods to treat pain locally

Cyclopropyl pyrrolidine orexin receptor antagonists

AMINO ACID COMPOSITION

Treatment of female fertility conditions through modulation of the autonomic nervous system

COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL

Compositions for the Treatment and Prevention of Heart Disease and Methods of Using Same

Nutritive compositions and methods of using same

1-methylnicotinamide derivatives and formulations for treatment of lipoprotein abnormalities

Pharmaceutical compositions comprising 2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl-benzyl)-(2S-phenylpiperidin-3S-yl-)

PHARMACEUTICAL COMPOSITIONS COMPRISING 3,5-DIAMINO-6-(2,3-DICHLOPHENYL)-1,2,4-TRIAZINE OR R(-)-2,4-DIAMINO-5-(2,3-DICHLOROPHENYL)-6-FLUOROMETHYL PYRIMIDINE AND AN NK1

S-Nitrosothiol Compounds and Related Derivatives

MODULATION OF AMINO ACID METABOLISM IN THE HYPOTHALAMUS

AMINO ACID AND ITS USES

W/O/W EMULSION COMPOSITION

Inhibitor for the formation of gamma-secretase complex

MEDICINAL COMPOSITIONS QUICKLY DISINTEGRATING IN THE ORAL CAVITY AND PROCESS FOR PRODUCING THE SAME

Hepatitis C virus inhibitors

Nitric oxide amino acid ester compound, compositions for increasing nitric oxide levels and method of use

REDUCING ER STRESS IN THE TREATMENT OF OBESITY AND DIABETES

USE OF ALPHA-KETOGLUTARIC ACID FOR THE TREATMENT OF HIGH PLASMA GLUCOSE CONDITION

LIPID-AMINO ACID CONJUGATES AND METHODS OF USE

TREATMENT AND PREVENTION OF CARDIOVASCULAR EVENTS

S-Nitrosothiols Containing Composition for the Treatment of Fatty Liver Diseases, Obesity and Other Diseases Associated with the Metabolic Syndrome and the Use of Such Compositions

USE OF ARCHAEA TO MODULATE THE NUTRIENT HARVESTING FUNCTIONS OF THE GASTROINTESTINAL MICROBIOTA

Compounds and Compositions for Use in the Prevention and Treatment of Disorders of Fat Metabolism and Obesity

METHODS OF TREATMENT OF UTERINE PATHOLOGICAL CONDITIONS

Method for Reducing Levels of Disease Associated Proteins

Statin and omega-3 fatty acids for reduction of Apo-B levels

5 HT RECEPTOR MEDIATED NEUROGENESIS

Pharmaceutical formulations for the treatment of alzheimer's disease

Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging

Control of blood vessel physiology to treat skin disorders

Combination Therapy

PHARMACEUTICAL COMPOSITIONS COMPRISING NK1 RECEPTOR ANTAGONISTS AND SODIUM CHANNEL BLOCKERS

5 HT RECEPTOR MEDIATED NEUROGENESIS

PHARMACEUTICAL COMPOSITIONS COMPRISING NK1 RECEPTOR ANTAGONISTS AND SODIUM CHANNEL BLOCKERS

Aporphine derivatives and pharmaceutical use thereof

Pharmaceutically acceptable salts of aporphine derivatives and carboxyl group-containing agents and methods for preparing the same

Medicament for Use in Connection With Cartilage Impairment

Compositions comprising balaglitazone and further antidiabetic compounds

ATORVASTATIN FORMULATION

Hepatitis C virus inhibitors

Uses of Amino Acid and Amino Acid Supplements Thereof

OXYMETHYLENE ARYL COMPOUNDS AND USES THEREOF

METHODS AND COLLAGEN PRODUCTS FOR TISSUE REPAIR

MANNITOL AND/OR PROLINE FOR PREVENTION AND TREATMENT OF AGEING RELATED SYMPTOMS

Statin and Omega-3 Fatty Acids For Lipid Therapy

ACE INHIBITOR-VASOPRESSIN ANTAGONIST COMBINATIONS

PHARMACEUTICAL COMPOSITIONS OF MUSCARINIC RECEPTOR ANTAGONISTS

COMBINATIONS COMPRISING HCV PROTEASE INHIBITOR(S) AND HCV IRES INHIBITOR(S), AND METHODS OF TREATMENT RELATED THERETO

COMPOSITIONS AND METHODS FOR AMELIORATING CACHEXIA

Use of allymercaptocaptopril for treating or preventing obesity and obesity related diseases

STABLE ATORVASTATIN FORMULATIONS

USE OF AGENTS THAT PREVENT THE GENERATION OF AMYLOID-LIKE PROTEINS AND/OR DRUSEN, AND/OR USE OF AGENTS THAT PROMOTE SEQUESTRATION AND/OR DEGRADATION OF, AND/OR PREVENT THE NEUROTOXIC EFFECTS OF SUCH PROTEINS IN THE TREATMENT OF MACULAR DEGENERATION

PHARMACEUTICAL COMPOSITIONS OF ATORVASTATIN

BILAYER TABLET FOR PREVENTING CARDIOVASCULAR EVENTS

CONTROLLED ABSORPTION OF STATINS IN THE INTESTINE

Cancer Treatment

Inhibition of the renin-angiotensin system for the treatment of renal, vascular and cartilage pathology

TREATMENT OF DISEASES USING ICE INHIBITORS

Combinations of SAP depleting agents and anti-SAP antibodies

Combination therapy for the treatment of chronic renal failure with an angiotensin II receptor antagonist and beraprost

USE OF SUGAR PHOSPHATES, SUGAR PHOSPHATE ANALOGS, AMINO ACIDS AND/OR AMINO ACID ANALOGS FOR MODULATING THE GLUCOLYSIS-ENZYME COMPLEX, THE MALATE ASPARATE SHUTTLE AND/OR THE TRANSAMINASES

MULTI-PHASIC, NANO-STRUCTURED COMPOSITIONS CONTAINING A COMBINATION OF A FIBRATE AND A STATIN

Matrix-Controlled Transdermal System Comprising Salts of ACE Inhibitor Dicarboxylic Acids

COSMETIC AND PHARMACEUTICAL COMPOSITIONS COMPRISING ACE INHIBITORS AND/OR ANGIOTENSIN II RECEPTOR ANTAGONISTS

PHOTO-PROTECTIVE DERMATOLOGICAL FORMULATIONS AND METHODS OF USING THE SAME

Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory disease

Treatment for Cardiovascular Disease

METHOD OF TREATMENT OF CARDIAC AND/OR RENAL FAILURE USING A CALCIUM CHANNEL BLOCKER AND AN ANGIOTENSIN CONVERTING ENZYME INHIBITOR OR AN ANGIOTENSIN II RECEPTOR BLOCKER

Statin-carboxyalkylether combinations

COMBINATION THERAPY COMPRISING ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND VASOPRESSIN RECEPTOR ANTAGONISTS

Amino acid composition and supplementary liquid containing the same

Class of therapeutics that enhance small molecule diffusion

Method and composition for treating heart failure

Use of nitrooxyderivatives of drug for the treatment of muscular dystrophies

Cancer Therapy

Method of regulating glucose metabolism, and reagents related thereto

MAST CELL-DERIVED RENIN

Methods for improving glycemic control in humans

Composition and method for reducing allergen

Use of Inhibitors of the Renin-Angiotensin System

ORAL PREPARATION FOR PROMOTING SYNTHESIS OF TISSUE COLLAGEN

METHODS FOR TREATING DISORDERS ASSOCIATED WITH HYPERLIPIDEMIA IN A MAMMAL

Novel Pharmaceutical

Methods of Inactivating Viruses

Omega-3 Fatty Acids and Dyslipidemic Agent for Lipid Therapy

Receptor function regulator

Methods of controlling proliferation and differentiation of stem and progenitor cells

COMBINATION OF AN DPP-IV INHIBITOR AND A PPAR-ALPHA COMPOUND

Methods of treating underlying inflammation from COPD or asthma

Medical Devices and Coatings Therefor

HMGCR isoforms in prediction of efficacy and identification of cholesterol-modulating compounds

Crystalline Forms Of [R-(R*,R*)-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methyl- Ethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid Calcium Salt (2:1)

Wound-Healing Pharmaceutical Compositions in the Form of a Cream Based on Amino Acids and Sodium Hyaluronate

Combination of Prostaglandin E2 Receptor Antagonists and Renin-Angiotensin System Inhibitors for Treating Renal Diseases

AMINO ACID SUPPLEMENTATION FOR A HEALTHY MICROBIOTA ECOSYSTEM

Prolyl Oligopeptidase Inhibitors Ameliorating Recovery From Brain Trauma

Compositions for Lowering Serum Cholesterol and/or Triglycerides

Ophthalmic Pharmaceutical Compositions Based on Amino Acids and Sodium Hyaluronate

Compounds inhibiting the binding of sap for treating osteoarthritis

Composition and Method For the Promotion of Hair Growth on a mammal

HDL-boosting combination therapy complexes

COMPOSITIONS AND METHODS FOR REDUCING CARDIOVASCULAR MORBIDITY AND/OR MORTALITY

HAEMOSTATIC COMPOSITION AND METHOD

Crystalline forms of [R-(R*, R*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)

Compositions and Therapeutic Use of N-Acetyl Aldosamines and N-Acetylamino Acids

Composition for the Treatment of Vitiligo

Cosmetic and pharmaceutical compositions comprising lauroyl proline and an ester of anhydrohexitol and of an aliphatic carboxylic acid

Combination of Organic Compounds

Preventive or therapeutic agents for decubitus

Stable Oral Pharmaceutical Composition

METABOTROPIC GLUTAMATE RECEPTOR ACTIVATOR

Methods for treating conditions associated with the accumulation of excess extracellular matrix

Modulation of Neurogenesis By Melatoninergic Agents

AMINO ACID COMPOSITION

Gel preparation for oral administration

Nanoparticles for drug delivery

Pharmaceutical Combination of Angiotensin II Antagonists and Angiotensin I Converting Enzyme Inhibitors

Therapeutic combination of a VEGF antagonist and anti-hypertensive agent

Treatment of metabolic syndrome with norfluoxetine

Therapeutic compositions comprising chorionic gonadotropins and HMG CoA reductase inhibitors

Compositions and methods for reducing antimicrobial resistance of microbes

Pharmaceutical Combination of Angiotensin II Antagonists and Angiotensin I Converting Enzyme Inhibitors

USE OF DIPYRIDAMOLE OR MOPIDAMOL FOR TREATMENT AND PREVENTION OF FIBRIN-DEPENDENT MICROCIRCULATION DISORDERS

Composition and Method For Promoting the Production of and/or Enhancing the Activity of Fibulin-5

Device and method for treating osteolysis using a drug depot to deliver an anti-inflammatory agent

Oral Composition

Stable pharmaceutical compositions of calcium channel blocker and an ACE inhibitor

STATIN AND OMEGA-3 FATTY ACIDS FOR REDUCTION OF APO-B LEVELS

USE OF RADICAL-SCAVENGING COMPOUNDS FOR TREATMENT AND PREVENTION OF NO-DEPENDENT MICROCIRCULATION DISORDERS

Use of branched chain fatty acid amino acid salts and compositions thereof

PHARMACEUTICAL COMPOSITIONS HAVING NOVEL SCORING PATTERNS AND METHODS OF USING THOSE COMPOSITIONS

Controlled release formulations

Inhibition or Treatment of Dyskinesia

Medicinal composition for mitigating blood lipid or lowering blood homocysteine

Combination of Organic Compounds

Drug combination pharmaceutical compositions and methods for using them

Bioavailability and Improved Delivery of Alkaline Pharmaceutical Drugs

Mast cell-derived renin

Stable pharmaceutical compositions of 2-aza-bicyclo(3.3.0)-octane-3-carboxylic acid derivatives

Compositions and Methods for Treating Hypertension and Inflammation

Amorphous Atorvastatin Calcium

PHARMACEUTICAL USES FOR ALPHA2DELTA LIGANDS

Orally Administered Agent For Preventing Or Improving Dry Station Of Skin

Infusion fluid for dialysis patients

PHARMACEUTICAL USES FOR ALPHA2DELTA LIGANDS

Glutamine-Containing Energy Imparting Amino Acid Composition or Amino Acid Solution

Combination of anticholineric and β mimetics for the treatment of respiratory diseases

5 HT receptor mediated neurogenesis

Combinations of HMG CoA reductase inhibitors and negatively charged phospholipids and uses thereof

Oculoselective Drugs and Prodrugs

Compositions and methods for the treatment of cardiovascular disease

Composition and methods for alleviating symptoms of neurotoxicity

Bioactive-rich concentrates and nutritive and therapeutic products containing same

Alpha2delta ligands for the treatment of fibromyalgia and other disorders

STATIN STABILIZING DOSAGE FORMULATIONS

Dosage unit for cardioprotection

TRA COMBINATION THERAPIES

Nanoparticles for drug delivery

Methods and compositions for treatment of diastolic heart failure

Treatment for Cardiovascular Disease

Method for the improvement of neuronal regeneration

Amino acid composition for improving glucose tolerance

Method of Identifying Inhibitors of DHODH

Methods for Treating Cancer

Compounds that inhibit caspase activity for treating glaucoma

PHARMACEUTICAL USES FOR ALPHA2DELTA LIGANDS

Conjugated fatty acid based emulsion and methods for preparing and using same

Compositions and methods for treating cardiovascular, cerebrovascular and other vascular disease patients

Compositions for the treatment and prevention of heart disease and methods of using same

Modulation of neurogenesis by PDE inhibition

Chp-gemcitabine Combination Agents And Their Use As Anti-Tumor Agents

Peptidomimetic inhibitors of retroviral proteases and their use as antivirals

Combined use of a GLP-1 compound and another drug for treating dyslipidemia

Dipeptidyl peptidase IV inhibitors and their uses for lowering blood pressure levels

Method for treating resistant hypertension

STATIN AND OMEGA-3 FATTY ACIDS FOR LIPID THERAPY

Inhibition of tissue damage to skin from radiation treatment therapy

Combinations comprising alpha-2-delta ligands

Stabilized atorvastatin

Combination therapy for coronary artery disease

Method for the treatment of diabetes

Lipid metabolism improving agent

Pharmaceutical composition comprising i.a. vitamin c, magnesium green tea extract for retarding cardiovascular disease

External preparation

Compositions and Methods for Reducing Cholesterol and Inflammation

PHARMACEUTICAL USES FOR ALPHA2DELTA LIGANDS

PHARMACEUTICAL USES FOR ALPHA2DELTA LIGANDS

Inhibitor for the formation of y-secretase complex

Method of preventing or treating glaucoma

Methods and compositions for the treatment of lipodystrophy

Intravenous essential fatty acid emulsion

Combination Therapy

Combination of a dpp IV inhibitor and an antiobesity or appetite regulating agent

NOVEL COMPOSITION AND METHOD FOR THE TREATMENT OF HYPERTENSION

PHARMACEUTICALLY ACTIVE PYRROLIDINE ESTER DERIVATIVES

Method of regulating glucose metabolism, and reagents related thereto

Compositions and methods for treatment of inflammatory bowel disease

Composition and method for facilitating bone healing

Cancer treatment

Atorvastatin formulation

STABLE PHARMACEUTICAL COMPOSITIONS

Acetylated amino acids as anti-platelet agents, nutritional and vitamin supplements

HMGCoA reductase inhibitor combinations and uses thereof

Fasudil in combination therapies for the treatment of pulmonary arterial hypertension

Supplemental dietary composition for turning on anabolic switches in muscle, stimulating and/or optimizing protein synthesis, and/or potently signaling muscle building and/or growth via molecular pathways

Combination of at least two compounds selected from an AT1-receptorantagonist or an ACE inhibitor or a HMG-Co-A reductase inhibitor

Use of chp as an inhibitor of glutathione s-transferases and collagen IV

Organic nanoparticles and associated methods

Co-formulations or kits of bioactive agents

Pharmaceutical Combination of Angiotensin II Antagonists and Angiotensin I Converting Enzyme Inhibitors

Methods for treating disorders associated with hyperlipidemia in a mammal

Methods for treating disorders associated with hyperlipidemia in a mammal

Use of Vitamin Ds or Vitamin D analogs to treat cardiovascular disease

Methods for treating disorders associated with hyperlipidemia in a mammal

Nutritional composition for wound healing

Prevention of hiv-1 infection by inhibition of rho-mediated reorganization and/or content alteration of cell membrane raft

Use of radical-scavenging compounds for treatment and prevention of NO-dependent microcirculation disorders

Sialidase inhibitors for the treatment of cardiovascular disease

Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection

Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection

Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

Film coated tablet for improved upper gastrointestinal tract safety

DRUGS FOR TREATING DIABETES

Methods of facilitating neural cell survival using non-peptide and peptide BDNF neurotrophin mimetics

BENZAMIDE AND BENZOATE ANTI-HIV COMPOUNDS

Drugs coated on a device to treat vulnerable plaque

Synergistic effects of amlodipine and atorvastatin metabolite as a basis for combination therapy

Treatment with azetidinone-based cholesterol absorption inhibitors and omega-3 fatty acids and a combination product thereof

Amino acid supplementation for a healthy microbiota ecosystem

Alpha 2 delta ligands for post-traumatic stress disorder

Pharmaceutical composition and method for the treatment of diseases using HMG-CoA reductase inhibitors and insulin secretion enhancers or sensitizers

Method of identifying inhibitors of DHODH

Compositions for reducing the incidence of drug induced arrhythmia

Methylnicotinamide derivatives and formulations for treatment of lipoprotein abnormalities

Composition for improving the efficacy and reducing the side effects of omega 3 fatty acids, fish oils and cardiovascular and diabetic treatments

Novel pharmaceutical granulate

Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection

Compositions comprising balaglitazone and further antidiabetic compounds

Composition and method for treating hypertension

Statins (HMG-COA reductase inhibitors) as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent

Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents

Combination therapy for glycaemic control

Tgf-beta antagonists combined with renin-angiotensin-aldosteron-system antagonists for treating renal insufficiency

Compositions and methods for the treatment of muscular dystrophy

Lklf/klf2 gene expression promoter

Sodium channel modulators

Antibacterial agents

Nutrition formulations and methods of providing nutrition formulations

Pharmaceutical compositions for treating or preventing coronary artery disease

METHOD OF PREVENTION AND TREATMENT OF AGING, AGE-RELATED DISORDERS AND/OR AGE-RELATED MANIFESTATIONS INCLUDING ATHEROSCLEROSIS, PERIPHERAL VASCULAR DISEASE, CORONARY ARTERY DISEASE, OSTEOPOROSIS, ARTHRITIS, TYPE 2 DIABETES, DEMENTIA, ALZHEIMERS DISEASE AND CANCER

Anti-obesity agent

Methods of treating obsessive compulsive disorder

Administration of macrophage targeted formulations of compounds which modulate cholesterol-metabolizing enzymes for treatment of atherosclerosis